Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 197 citing articles:

Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance
Jiahui Chen, Rui Wang, Nancy Benovich Gilby, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 2, pp. 412-422
Open Access | Times Cited: 639
Impact of the Delta variant on vaccine efficacy and response strategies
Lianlian Bian, Qiushuang Gao, Fan Gao, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1201-1209
Open Access | Times Cited: 215
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
Vikram Thakur, Shivam Bhola, Pryanka Thakur, et al.
Infection (2021) Vol. 50, Iss. 2, pp. 309-325
Open Access | Times Cited: 165
A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 118
Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants
Vladimir А. Gushchin, Inna V. Dolzhikova, А. М. Щетинин, et al.
Vaccines (2021) Vol. 9, Iss. 7, pp. 779-779
Open Access | Times Cited: 114
Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: Their significant mutations in S‐glycoprotein, infectivity, re‐infectivity, immune escape and vaccines activity
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 107
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
Manish Dhawan, Abhilasha Sharma, Priyanka Choudhary, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 87
Omicron BA.2 (B.1.1.529.2): High Potential for Becoming the Next Dominant Variant
Jiahui Chen, Guo‐Wei Wei
The Journal of Physical Chemistry Letters (2022) Vol. 13, Iss. 17, pp. 3840-3849
Open Access | Times Cited: 83
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
Meriem Bekliz, Kenneth Adea, Pauline Vetter, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 78
Argonaute-integrated isothermal amplification for rapid, portable, multiplex detection of SARS-CoV-2 and influenza viruses
Xingyu Ye, Haiwei Zhou, Xiang Guo, et al.
Biosensors and Bioelectronics (2022) Vol. 207, pp. 114169-114169
Open Access | Times Cited: 77
Emerging Vaccine-Breakthrough SARS-CoV-2 Variants
Rui Wang, Jiahui Chen, Yuta Hozumi, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 3, pp. 546-556
Open Access | Times Cited: 73
Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies
Nur Zawanah Zabidi, Hern Liang Liew, Isra Ahmad Farouk, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 944-944
Open Access | Times Cited: 59
Mechanisms of SARS-CoV-2 Evolution Revealing Vaccine-Resistant Mutations in Europe and America
Rui Wang, Jiahui Chen, Guo‐Wei Wei
The Journal of Physical Chemistry Letters (2021) Vol. 12, Iss. 49, pp. 11850-11857
Open Access | Times Cited: 97
Perspectives on SARS-CoV-2 Main Protease Inhibitors
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 23, pp. 16922-16955
Open Access | Times Cited: 93
Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India
Nivedita Gupta, Harmanmeet Kaur, Pragya D. Yadav, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1782-1782
Open Access | Times Cited: 87
Monitoring SARS-CoV-2 variants alterations in Nice neighborhoods by wastewater nanopore sequencing
Géraldine Rios, Caroline Lacoux, Vianney Leclercq, et al.
The Lancet Regional Health - Europe (2021) Vol. 10, pp. 100202-100202
Open Access | Times Cited: 82
Current and future nanoparticle vaccines for COVID-19
Mai N. Vu, Hannah G. Kelly, Stephen J. Kent, et al.
EBioMedicine (2021) Vol. 74, pp. 103699-103699
Open Access | Times Cited: 80
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination
Prerna Arora, Anzhalika Sidarovich, Nadine Krüger, et al.
Cell Reports (2021) Vol. 37, Iss. 2, pp. 109825-109825
Open Access | Times Cited: 78
Revealing the Threat of Emerging SARS-CoV-2 Mutations to Antibody Therapies
Jiahui Chen, Kaifu Gao, Rui Wang, et al.
Journal of Molecular Biology (2021) Vol. 433, Iss. 18, pp. 167155-167155
Open Access | Times Cited: 70
Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance.
Jiahui Chen, Rui Wang, Nancy Benovich Gilby, et al.
arXiv (Cornell University) (2021)
Open Access | Times Cited: 66
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
Differences in Clinical Characteristics Between Delta Variant and Wild-Type SARS-CoV-2 Infected Patients
Zhenkui Hu, Xing Huang, Jianguo Zhang, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 58
Omicron BA.2 (B.1.1.529.2): high potential to becoming the next dominating variant
Jiahui Chen, Guo‐Wei Wei
Research Square (Research Square) (2022)
Open Access | Times Cited: 58
The Role of Digital Technology in Curbing COVID-19
Noha Saeed Alghamdi, Saeed M. Alghamdi
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 14, pp. 8287-8287
Open Access | Times Cited: 53
Persistent Laplacian projected Omicron BA.4 and BA.5 to become new dominating variants
Jiahui Chen, Yuchi Qiu, Rui Wang, et al.
Computers in Biology and Medicine (2022) Vol. 151, pp. 106262-106262
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top